Sickle Cell Disease African Scientific Symposium 2026

Theme

Accelerating Drug Development for Sickle Cell Disease in Africa

  • đź“Ť Marriott Hotel, Ikeja
  • đź“… July 30–31, 2026
  • ⏰ 8:00 AM – 5:00 PM
Register Now
SCD Scientific Symposium
30th
July
31st
July
Event starts in: -- days --:--:--
Google Calendar iCal / Outlook
Overview
The Sickle Cell Disease African Scientific Symposium is a patient-centered, Africa-led platform designed to accelerate credible SCD innovations from scientific insight into structured drug discovery and development pathways. It connects indigenous scientific knowledge and emerging research with the practical requirements of evidence-based medicine, rigorous data generation, ethical oversight, regulatory readiness, and development best practices so solutions can advance responsibly and efficiently toward patient benefit.
The Symposium convenes a curated, invite-only ecosystem of scientists, clinicians, regulators, technical partners, investors, manufacturers, and patient advocacy groups to align on what “success” should look like for people living with SCD and how to measure it.
A defining focus is ensuring Patient Voice in R&D is embedded early, including the integration of patient-centered study design and outcomes that reflect lived experience (e.g., function, pain impact, treatment burden, quality of life) alongside clinical and laboratory endpoints.

Registration Form

Spaces are limited to ensure a high-value, interactive experience. Register to 
reserve your complimentary spot.

SCD Scientific Symposium

Personal Information

Overview
The Sickle Cell Disease African Scientific Symposium is a patient-centered, Africa-led platform designed to accelerate credible SCD innovations from scientific insight into structured drug discovery and development pathways. It connects indigenous scientific knowledge and emerging research with the practical requirements of evidence-based medicine, rigorous data generation, ethical oversight, regulatory readiness, and development best practices so solutions can advance responsibly and efficiently toward patient benefit.
The Symposium convenes a curated, invite-only ecosystem of scientists, clinicians, regulators, technical partners, investors, manufacturers, and patient advocacy groups to align on what “success” should look like for people living with SCD and how to measure it.
A defining focus is ensuring Patient Voice in R&D is embedded early, including the integration of patient-centered study design and outcomes that reflect lived experience (e.g., function, pain impact, treatment burden, quality of life) alongside clinical and laboratory endpoints.